MPP (C-TAP) – Biotech Africa, COVID-19 Diagnostic, Patent & Material Sublicense Agreement Post author:GHIAA Admin Post published:January 25, 2024 Post category: Continue ReadingMPP (C-TAP) – Biotech Africa, COVID-19 Diagnostic, Patent & Material Sublicense Agreement
UC Berkeley, Therapeutics & Diagnostics, Exclusive License Agreement Template Post author:GHIAA Admin Post published:November 30, 2023 Post category: Continue ReadingUC Berkeley, Therapeutics & Diagnostics, Exclusive License Agreement Template
University of Chile – MPP (C-TAP), COVID-19 Diagnostic Material & Know-How License Agreement Post author:GHIAA Admin Post published:September 25, 2023 Post category: Continue ReadingUniversity of Chile – MPP (C-TAP), COVID-19 Diagnostic Material & Know-How License Agreement
PHS (NIH/CDC/FDA), Model Exclusive Patent License Agreement Post author:GHIAA Admin Post published:August 31, 2023 Post category: Continue ReadingPHS (NIH/CDC/FDA), Model Exclusive Patent License Agreement
PHS (NIH/CDC/FDA), Model Non-Exclusive Patent License Agreement Post author:GHIAA Admin Post published:August 29, 2023 Post category: Continue ReadingPHS (NIH/CDC/FDA), Model Non-Exclusive Patent License Agreement
NIH – Fluidigm, COVID-19 Diagnostic Development Agreement Post author:GHIAA Admin Post published:August 23, 2023 Post category: Continue ReadingNIH – Fluidigm, COVID-19 Diagnostic Development Agreement
FIND Sample Funding Terms and Conditions Post author:GHIAA Admin Post published:December 7, 2022 Post category: Continue ReadingFIND Sample Funding Terms and Conditions
AXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement Post author:GHIAA Admin Post published:September 13, 2022 Post category: Continue ReadingAXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement
NIH – MPP (C-TAP), COVID-19 Technologies, Patent and Biological Material License Agreement Post author:GHIAA Admin Post published:June 29, 2022 Post category: Continue ReadingNIH – MPP (C-TAP), COVID-19 Technologies, Patent and Biological Material License Agreement